Report #2852455

Overview

Sex

Female

Age

Age unknown

State

MT

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

late for her 2nd dose of the accelerated schedule for Twinrix; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received 1st dose on an unknown date). On an unknown date, the patient received the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: late for her 2nd dose of the accelerated schedule for Twinrix). The outcome of the drug dose administration interval too long was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-JUL-2025 The patient self-reported this case. The patient was late for her 2nd dose of the accelerated schedule for Twinrix. The patient received 2nd dose of Twinrix, later than the recommended interval, which led to lengthening of vaccination schedule.